Background {#Sec1}
==========

Canonical Notch signaling is induced by cell-cell interactions between a Notch receptor and a Notch ligand \[[@CR1]\]. There are four mammalian Notch receptors (NOTCH1 to NOTCH4) and five Notch ligands (DLL1, DLL3, DLL4, JAG1 and JAG2). The extracellular domain (ECD) of Notch receptors comprises 29--36 EGF repeats that may be modified by O-glycans \[[@CR2]--[@CR4]\]. O-fucose glycans are initiated by the transfer of fucose from GDP-fucose by POFUT1 at Ser/Thr in the consensus sequence C~2~XXXXS/TC~3~ between the second and third cysteines of an EGF repeat \[[@CR5]\]. There are 21 O-fucose glycan consensus sequences in the 36 EGF repeats of NOTCH1 and a similar number in the other Notch ECDs. Experiments in *Drosophila* determined that deletion of EGF11 and EGF12 destroys Notch ligand binding and defined a Notch ligand binding domain \[[@CR6]\]. EGF12 of both *Drosophila* and mammalian Notch carry O-fucose \[[@CR7], [@CR8]\] and X-ray crystallography of co-crystals between fragments of NOTCH1 and DLL4 \[[@CR9]\] as well as NOTCH1 and JAG1 \[[@CR10]\] revealed that O-fucose on EGF12 plays a key role in binding interactions between NOTCH1 and both ligands.

Conversion of Thr to Ala in the EGF12 O-fucose consensus site of *Drosophila* Notch precludes the addition of O-fucose to EGF12, and results in embryos that go through neurogenesis but fail to exhibit Notch signaling at the dorsal/ventral boundary of the wing disc \[[@CR11]\]. In vitro binding assays revealed that there is a marked loss in the ability of Fringe (which adds a N-acetylglucosamine to O-fucose in EGF repeats) to inhibit the binding of Serrate to Notch lacking O-fucose in EGF12 \[[@CR11]\]. However, Fringe markedly enhances the binding of both Delta and Serrate to *Drosophila* Notch when O-fucose is absent from EGF12 \[[@CR11]\]. Thus, when all other O-fucose sites remain intact and can be modified by Ofut1 and Fringe, the loss of O-fucose in EGF12 primarily has an effect on Serrate/Notch interactions. Interestingly, a recombinant mammalian NOTCH1 fragment containing EGF12 lacking O-fucose does bind to Notch ligands in vitro in the presence of calcium \[[@CR12]\].

Notch signaling in mice is very similar to Notch signaling in humans. Since disrupted Notch signaling causes numerous human pathologies \[[@CR13]\], defining mechanisms of Notch signaling in mice provides insights into human disease. Introduction of the Thr to Ala mutation (Thr466Ala) in EGF12 of a mouse *Notch1* cDNA causes the resulting mutant NOTCH1\[12f\] to be inactive in a Notch signaling reporter assay \[[@CR14]\]. Reversion of the mutation in the mutant cDNA rescues Notch signaling. Introduction of a Ser in place of Ala in the *Notch1*\[12f\] cDNA allows the acquisition of O-fucose and the concomitant rescue of Notch signaling. Thus, in cultured mammalian cells, the presence of O-fucose on EGF12 is necessary for Notch signaling. Therefore, it was surprising to find that *Notch1*\[12f/12f\] mouse homozygotes are viable and fertile \[[@CR15], [@CR16]\]. The *Notch1*\[12f\] allele is hypomorphic, however, since it only partially rescues a compound heterozygous *Notch1*\[12f/lbd\] mouse \[[@CR15]\]. *Notch1*\[lbd\] (*Notch1*^tm2.1Pst^) is a strong loss-of-function allele lacking 141 amino acids that include the NOTCH1 ligand binding domain \[[@CR17], [@CR18]\]. In this paper we show that *Notch1*\[12f\] becomes a strong loss-of-function allele after backcrossing at least 11 generations onto the C57BL/6 J background, and we reveal the existence of a modifier gene in either the 129129S2/SvPasCrl or C57BL/6J genome.

Results {#Sec2}
=======

C57BL/6 J *Notch1*\[12f/12f\] embryos die before birth {#Sec3}
------------------------------------------------------

The *Notch1*\[12f\] allele (*Notch1*^tm2Pst^) was originally characterized in mice of mixed genetic background. WW6 embryonic stem (ES) cells were engineered to carry a *Notch1* point mutation in exon 8 in a floxed targeting construct. WW6 ES cells are \~ 75% 129S2/SvPasCrl, \~ 20% C57BL/6 J and \~ 5% SJL \[[@CR19]\]. Chimeric mice were crossed to C57BL/6 J MeuCre40 mice \[[@CR20]\] to obtain the *Notch1*\[12f\] allele, and then crossed 5--7 generations to C57BL/6 J mice before heterozygotes were intercrossed and their progeny characterized \[[@CR15]\]. This colony was maintained over several years by heterozygote crosses and progeny were obtained at the expected Mendelian frequency. Backcrossing of heterozygotes to C57BL/6 J males and females was subsequently performed in a separate cohort until *Notch1*\[12f/+\] heterozygotes of the eleventh backcross generation were intercrossed. When several pairs did not give rise to *Notch1*\[12f/12f\] homozygous progeny at the expected frequency (Table [1](#Tab1){ref-type="table"}, 1^st^ cohort), we performed Southern analysis and quantitative PCR of genomic DNA of *Notch1*\[12f/+\] heterozygotes to determine if there were copy number or structural changes in the *Notch1*\[12f\] gene. Digestion with HindIII or Kpn1 gave bands of the expected size for *Notch1*\[+\] and *Notch1*\[12f\] alleles, with no additional bands (Fig. [1](#Fig1){ref-type="fig"}). Primers that spanned a *loxP* site in the *Notch1*\[12f\] allele and primers specific for the *Notch1*\[+\] allele were used to determine copy number in *Notch1*\[+\] and *Notch1*\[12f\] genomic DNA, as described in Methods. Heterozygous mice proven to carry one copy each of a wild type and a mutant allele, and Kpn1 bands from *Notch1*\[+\] and *Notch1*\[12f\] of equivalent intensity (Fig. [1](#Fig1){ref-type="fig"}) determined by NIH Image J, were used for timed mating of heterozygous Notch1\[12f/+\] mice. Table 1Embryonic lethality of *Notch1*\[12f/12f\] after backcrossing to C57BL/6 JCrossIntercross Pairs (Litters)*Notch1* \[+/+\]*Notch1* \[12f/+\]*Notch1* \[12f/12f\]Chi-Squared TestToronto *Notch1*\[12f/+\] X Toronto *Notch1*\[12f/+\]5 (8)183614*Expected ratio*173417*P* = 0.7Backcrossed 11 generations (1st cohort)19 (65)10317813C57BL/6 J.*Notch1*\[12f/+\]XC57BL/6 J*.Notch1*\[12f/+\]*Expected ratio*7414774*P* = 1.57e-15Backcrossed 15 generations (2nd cohort)9 (9)19332C57BL/6 J.*Notch1*\[12f/+\]XC57BL/6 J*.Notch1*\[12f/+\]*Expected ratio*142714*P = 0.0013* Fig. 1Southern blot analysis. Genomic DNA prepared from *Notch1*\[+/+\], *Notch1*\[12f/+\] and *Notch1*\[12f/12f\] progeny of a heterozygous Notch1\[12f/+\] cross, was digested with HindIII or KpnI, subjected to agarose gel electrophoresis, transferred to membrane and probed with the DNA fragment shown on the diagram of the *Notch1*\[12f\] allele. Numbered boxes represent introns. MCS, multiple cloning site of the targeting vector

We also reacquired *Notch1*\[12f/12f\] homozygotes from a colony established in Toronto from *Notch1*\[12f/12f\] males we sent. The latter were backcrossed 3 times to C57BL/6 J mice and maintained by intercrossing before sending us male homozygotes. These mice were used to independently replicate our published data \[[@CR15]\] showing reduced numbers of thymocytes in *Notch1*\[12f/12f\] homozygotes (not shown). After crossing the *Notch1*\[12f/12f\] homozygotes from the Toronto colony once to C57BL/6 J, we used qPCR of genomic DNA to show that the resulting heterozygotes each had a single copy of *Notch1*\[+\] and *Notch1*\[12f\]. These mice were intercrossed and shown to generate viable *Notch1*\[12f/12f\] homozygotes at the expected Mendelian frequency (Table [1](#Tab1){ref-type="table"}). Heterozygotes were separately backcrossed to C57BL/6 J for up to 15 generations and then intercrossed. As previously observed in our colony after 11 backcrosses, this second set of backcrossed *Notch1*\[12f/+\] heterozygotes rarely generated viable *Notch1*\[12f/12f\] homozygotes (Table [1](#Tab1){ref-type="table"}, 2^nd^ cohort). Analysis of embryos from timed mating of *Notch1*\[12f/+\] heterozygotes revealed that embryonic lethality of C57BL/6 J *Notch1*\[12f/12f\] homozygotes occurred by E11.5 (Table [2](#Tab2){ref-type="table"}). Table 2Stage of embryonic lethality in *Notch1*\[12f/12f\] embryosEmbryo StageNo. LittersGenotype*Notch1* \[+/+\]*Notch1* \[12f/+\]*Notch1* \[12f/12f\]E9.536168 (1 dying)E10.5412246 (1 dying)E10.7523121E11.535154 (all dying)E12.51350Timed mating was performed as described in Methods

*Notch1*\[12f/12f\] embryos exhibit a milder phenotype than typical notch pathway mutants {#Sec4}
-----------------------------------------------------------------------------------------

E9.5 mouse embryos with defective Notch signaling exhibit highly disorganized vascularization of the yolk sac \[[@CR21]--[@CR25]\]. In C57BL/6 J *Notch1*\[12f/12f\] embryos of E9.5 to E11.5, the yolk sac was poorly vascularized with major blood vessels ill-defined compared to control littermates which had a clear vascular tree with prominent blood vessels at each stage (Fig. [2](#Fig2){ref-type="fig"}). The overall morphology of wild type and heterozygous embryos was similar to *Notch1*\[12f/12f\] mutants at E9.5 (Fig. [3](#Fig3){ref-type="fig"}). However, based on comparisons of their Theiler stage (TS) \[[@CR26]\], E9.5 *Notch1*\[12f/12f\] homozygotes were delayed in development compared to littermates. They had a significant reduction in the total number of somites at E9.5 (Table [3](#Tab3){ref-type="table"}), mutant embryos were relatively anemic and close to TS14-late or TS15-early, whereas littermates were more similar to TS15-late (Fig. [3](#Fig3){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Figure S1). By E10.5, mutant embryos were similarly less developed and more anemic than controls (Fig. [3](#Fig3){ref-type="fig"} and Additional file [2](#MOESM2){ref-type="media"}: Figure S2), and by E11.5 dying mutants exhibited a strong Notch signaling-defective phenotype with an enlarged pericardial sac and small heart, severely truncated somites and general regression of most tissues (Fig. [3](#Fig3){ref-type="fig"}). In general, overall body size of *Notch1*\[12f/12f\] homozygotes was smaller, features were less defined, the heart and mandibular arches were generally smaller and limb buds less developed. Staining with anti-PECAM1 of E10.5 embryos highlights these features (Additional file [3](#MOESM3){ref-type="media"}: Figure S3). The staining intensity was somewhat reduced in *Notch1*\[12f/12f\] embryos and vascularization appeared slightly more sparse. Fig. 2Yolk sac vascularization in *Notch1*\[12f/12f\] embryos. *Notch1*\[12f/+\] mice that had been backcrossed 11 generations to C57BL/6 J mice were subjected to timed mating as described in Methods, embryos were dissected at E9.5, E10.5 and E11.5 and photographed using an inverted dissecting microscope Fig. 3Morphology of *Notch1*\[12f/12f\] embryos. Embryos were obtained at E9.5, E10.5 and E11.5 as described in the legend to Fig. [2](#Fig2){ref-type="fig"} and photographed under an inverted dissecting microscope. Their Theiler stage was determined by comparison of morphological features including number of somites, presence, delimitation and size of forelimb bud and hindlimb bud, branchial arch number and size, shape and size of the heart and head regions, olfactory placode indentation and closure of the otocyst. Other E9.5 and E10.5 embryos are shown in Additional files [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"}; Figures S1, S2 Table 3Number of somites in *Notch1*\[12f/12f\] embryosE9.5 EmbryosNo. SomitesMean (SEM)Student's t test^a^*Notch1*\[+/+\] (*n* = 5)23, 24, 25, 24, 2324 (+/− 0.37)*Notch1*\[12f/12f\] (*n* = 4)21, 20, 20, 1920 (+/− 0.41)*P* = 0.0003^a^Unpaired Student's t test with Welch's correction

To determine whether a mutation of the *Notch1*\[12f\] gene might have occurred during backcrossing that could explain the embryonic lethality of *Notch1*\[12f/12f\] embryos, cDNA from wild type and E9.5 homozygous mutant embryo heads was prepared. Sequencing of cDNAs obtained from PCR products using 12 overlapping primers that spanned the entire coding region (Additional file [4](#MOESM4){ref-type="media"}: Table S1) gave the expected mutant sequence of *Notch1*\[12f\] cDNA, and no indication of a mixed sequence. The *Notch1* sequence obtained from *Notch1*\[12f/12f\] embryos contained the nucleotide changes introduced to generate the *Notch1*\[12f\] (T466A) knock-in allele and the introduced *Sph*1 restriction site \[[@CR15]\]. Thus, no mutation or rearrangement had inactivated the *Notch1* gene during backcrossing of *Notch1*\[12f/+\] mice to the 15th generation.

To determine if Notch signaling was reduced in the presomitic mesoderm (PSM), in situ hybridization of *Uncx*4.1 and *Dll3* was performed. Previous studies of Notch pathway mutants have shown reduced expression of these genes at E9.5 \[[@CR21], [@CR27], [@CR28]\]. However, we observed similar signals for control and mutant embryos at E9.5 (Fig. [4](#Fig4){ref-type="fig"}). Western blot analysis to detect cleaved NOTCH1 intracellular domain (NICD1) as an indicator of Notch1 signaling was performed on the PSM of E10.5 embryos. The results showed variable NICD1 expression which did not indicate reduced cleavage in *Notch1*\[12f/12f\] embryos (Additional file [5](#MOESM5){ref-type="media"}: Figure S4). A subset of Notch pathway genes whose expression was previously shown by in situ hybridization to increase in defined brain regions of Notch-signaling defective *Pofut1* null embryos \[[@CR21]\], was investigated by qRT-PCR of the cDNA from *Notch1*\[12f/12f\] embryo heads. At E9.5, *Notch1*, *Jag1* and *Dll3* expression were significantly increased in *Notch1*\[12f/12f\] compared to wild type embryo transcripts in replicate experiments performed in triplicate using two housekeeping genes (Fig. [5](#Fig5){ref-type="fig"}), and in a Notch pathway qRT-PCR array using five housekeeping genes (not shown). In E10.5 embryos, *Uncx4.1* was significantly increased based on qRT-PCR analysis with *Actb* and *Gapdh* housekeeping genes (Fig. [5](#Fig5){ref-type="fig"}). Fig. 4In situ hybridization of E9.5 embryos. The somitic region of embryos obtained at E9.5 was subjected to in situ hybridization using a probe for *Uncx*4.1 or *Dll3* Fig. 5qRT-PCR of Notch pathway genes expressed by *Notch1*\[12f/12f\] embryos. RNA from E9.5 and E10.5 embryo and control heads (*n* = 3 of each) was converted to cDNA and tested in replicate qRT-PCR experiments using *Actb* and *Gapdh* housekeeping genes. Values for mutants and controls compared to each housekeeping gene were obtained and fold-difference between mutants and controls (taken as 1.0) was determined. The data were plotted using Prism version 8.0. Significance was determined by unpaired Student's t test, (\*) *p* = 0.07; \* *p* \< 0.05; \*\* *p* \< 0.005

Reversal of *Notch1*\[12f/12f\] lethality in a mixed genetic background {#Sec5}
-----------------------------------------------------------------------

To investigate the existence of a modifying gene that might have been lost during backcrossing, 15 generation backcrossed *Notch1*\[12f/+\] male and female mice were crossed to wild type 129S2/SvPasCrl mice. This strain was chosen because WW6 ES cells from which the original *Notch1\[*12f/12f\] mice were derived are \~ 75% 129S2/SvPasCrl \[[@CR19]\]. The resulting *Notch1*\[12f/+\] F1 progeny of mixed C57BL/6 J and 129S2/SvPasCrl background were intercrossed and the F2 progeny were genotyped. It is shown in Table [4](#Tab4){ref-type="table"} that *Notch1*\[12f/12f\] pups from the F2 intercross appeared at the expected Mendelian ratio of \~ 25%. Thus, a single outcross rescued the embryonic lethality of *Notch1*\[12f/12f\] embryos, providing strong evidence for the existence of a dominant modifying gene (or tightly-linked genes) outside the congenic footprint that rescues NOTCH1\[12f\] function in the C57BL/6 J:129S2/SvPasCrl mixed genetic background. The congenic footprint is defined as the genes that remain linked to *Notch1*\[12f\] after the 11\~15 backcrosses to C57BL/6 J mice \[[@CR29]\]. It is expected that these genes would derive from the predominant 129S2/SvPasCrl genome of WW6 cells \[[@CR29]\]. Table 4Intercross of *Notch1*\[12f/+\] F1 progeny obtained from the cross C57BL/6 J.*Notch1*\[12f/+\] X 129S2/SvPasCrl.*Notch1*\[+/+\]CrossNo. Pairs (No. Litters)*Notch1*\
\[+/+\]*Notch1*\
\[12f/+\]*Notch1* \[12f/12f\]Chi-Squared testC57BL/6 J.129S2/SvPasCrl*Notch1*\[12f/+\] F1XC57BL/6 J.129S2/SvPasCrl*Notch1*\[12f/+\] F16 (11)274224*Expected*234723*P* = 0.58

Discussion {#Sec6}
==========

In this paper we show that *Notch1*\[12f/12f\] homozygotes that are viable on a mixed background of C57BL/6 J and 129S2/SvPasCrl, die at \~E11.5 after 11--15 generations of backcrossing to C57BL/6 J mice. This phenomenon occurred after backcrossing heterozygotes derived from two colonies that were producing viable *Notch1*\[12f/12f\] homozygotes. The phenotype of C57BL/6 J *Notch1*\[12f/12f\] embryos resembles that of embryos with defective Notch signaling \[[@CR21]--[@CR25]\]. The yolk sac of *Notch1*\[12f/12f\] embryos exhibits fewer and disorganized blood vessels. Embryos of E9.5 have a slight reduction in the number of somites and are at an earlier Theiler stage of development than littermate controls. Homozygous embryos are no longer found by E12.5 and dying embryos at E11.5 are severely underdeveloped. Thus, *Notch1*\[12f/12f\] embryos live a day, or more, longer than embryos that lack NOTCH1 signaling \[[@CR21]--[@CR25]\]. The basis of their less severe phenotype in the developing embryo may be the presence of the many remaining O-glycans on Notch EGF repeats when only the EGF12 O-fucose glycan is absent \[[@CR3]\].

The chance of loci outside the congenic footprint of the *Notch1*\[12f\] gene being heterozygous after 15 generations of backcrossing is (1/2)^15--1^ or 0.000061 \[[@CR30]\]. It is expected that the congenic footprint derives from the 129S2/SvPasCrl genome since it is predominant in WW6 ES cells. The fact that a single intercross between C57BL/6 J/129S2/SvPasCrl F1 heterozygotes produced viable *Notch1*\[12f/12f\] pups in the expected Mendelian ratio suggests that a 129S2/SvPasCrl gene (or tightly linked genes) outside the congenic footprint is responsible for the viability of F2 *Notch1*\[12f/12f\] homozygotes. The fact that the loss of this modifying gene during backcrossing was not evident after \~ 7 backcrosses, when less than 1% of the genome would be 129S2/SvPasCrl, is surprising. However, both the viability of *Notch1*\[12f/12f\] mice from intercrosses after \~ 7 backcrosses, and the loss of viability after backrossing reached 11 or more generations, were observed in two cohorts maintained separately. This apparent paradox indicates that the "viability" gene may be linked to the *Notch1*\[12f\] allele on chromosome 2, though outside the congenic footprint.

The potential function(s) encoded by the 129S2/SvPasCrl modifying gene are myriad because the Notch signaling pathway is so complex \[[@CR21]--[@CR25]\]. It requires correct synthesis of a large membrane receptor, modification, processing and trafficking through the secretory pathway to the cell surface, stable expression at the cell surface, interaction with canonical ligands and endocytosis into the ligand-expressing cell. While there are only 5 canonical NOTCH1 ligands, there are numerous membrane and secreted proteins that bind to NOTCH1 ECD and may affect canonical Notch signaling \[[@CR31]\]. A modifier might be important for NOTCH1\[12f\] dimerization or oligomerization. We previously reported genetic evidence that *Notch1*\[12f\] compound heterozygotes with a null NOTCH1 ligand binding domain allele (*Notch1*\[lbd\] or *Notch1*^tm2.1Pst^) have a Notch developmental phenotype, whereas *Notch1*\[lbd/+\] heterozygotes do not, indicating cell surface interactions between the products of the *Notch1*\[12f\] and *Notch1*\[lbd\] alleles \[[@CR18]\]. Evidence from electron microscopy suggests that *Drosophila* Notch and mammalian NOTCH1, respectively, dimerize through their extracellular domains \[[@CR32]\]. A modifier could encode a molecule that assists transit of NOTCH1\[12f\] from the endoplasmic reticulum through Golgi compartments, or provides stability at the plasma membrane, or modifies NOTCH1\[12f\] through a post-translational mechanism to interact with Notch ligands. Previously identified modifiers of Notch signaling include Fringe which modulates the strength of Notch signaling via canonical Notch ligands \[[@CR33]\], DNER, a non-canonical Notch ligand \[[@CR34]\] and molecules of a variety of activities identified by genetic interactions \[[@CR35]--[@CR37]\] or modifier screens \[[@CR38]\]. An example of mouse background influencing a Notch signaling phenotype is *Jag1* mutant heterozygotes that exhibit a more severe inner ear phenotype on a C3H background compared to a C57BL/6 background, and eye dysmorphologies that manifest on a C57BL/6 background but are suppressed on a C3H background \[[@CR39]\]. Identifying the mechanism by which NOTCH1\[12f\] becomes functional will require isolating the modifying gene and showing how the activity it encodes enables NOTCH1\[12f\] to participate in Notch signaling.

The most straight-forward way to identify a modifier would be a SNP genotyping strategy on a large cohort of 129S2/SvPasCrl/C57BL/6 J *Notch1*\[12f/12f\] F2 progeny to locate a region of 129S2/SvPasCrl homology present in all progeny. This strategy was successful in genomic mapping of several recessive mutant genes with phenotypic traits using a small panel of 394 SNPs and a relatively modest number of F2 progeny \[[@CR40]\]. However, the regions mapped in that study varied from 17 to 83 Mb. By contrast, the Affymetrix Mouse Diversity Genotyping Array uses 63,000 SNPs with a potential of mapping to a region as small as 4.6 kb. A complementary strategy would be to transfect a range of cell types with the mouse *Notch1*\[12f\] cDNA shown previously to be inactive in ligand-induced Notch signaling in CHO cells \[[@CR14]\], identify a host cell that allows NOTCH1\[12f\] to function, and isolate the modifying gene from a cDNA expression library made from that cell. This would be facilitated if the gain-of-function phenotype was easy to screen for or for which to select. While each of these approaches would require considerable effort, it would potentially unearth a novel mechanism by which NOTCH1 with an inactivating point mutation that precludes the addition of O-fucose in the canonical Notch ligand binding domain can become functional. Such a mechanism may be in operation in cell types that do not completely lose Notch signaling when *Pofut1* is deleted. Examples include the inner ear \[[@CR41]\], hemopoietic stem cells \[[@CR42]\], and endocardial cells \[[@CR43]\].

Conclusion {#Sec7}
==========

We conclude that the viability of *Notch1*\[12f/12f\] homozygotes on the mixed genetic background generated by 5--7 backcrosses to C57BL/6 J mice after derivation of the targeted allele in WW6 ES cells, is due to the presence of a gene in the 129S2/SvPasCrl background. This modifier gene allows the production of viable *Notch1*\[12f/12f\] mice by rescuing NOTCH1\[12f\] function in Notch signaling.

Methods {#Sec8}
=======

Mice {#Sec9}
----

*Notch1*\[12f\](Notch1^tm2Pst^) mice were generated previously in WW6 embryonic stem (ES) cells by a targeted knockin strategy \[[@CR15]\]. C57BL/6 J mice were obtained from The Jackson Laboratory (Bar Harbor, MN) and 129S2/SvPasCrl mice were obtained from Charles River Laboratories, USA. Mice of both sexes and various ages from 7 weeks to 9 months were used in breeding. Mice were housed at a maximum of 5 mice per cage containing autoclaved 1/8th inch Bed-o'Cobs™ (Andersons Lab Bedding, Delphi, Indiana) in the mouse barrier facilities at the Albert Einstein College of Medicine (temperature 68° to 72 °F, humidity 30--70%, lights on at 6 am and off at 8 pm daily). Mice were fed ad libitum with LabDiet 5058 (PicoLab mouse diet 20).

Timed mating was performed to obtain embryos at different stages of gestation. A time of 0.5 days of gestation was taken as the first morning that a vaginal plug was observed in a female who had been placed with a male the evening before. Mice were sacrificed using asphyxiation to effect in a chamber containing CO~2~ delivered from a compressed gas cylinder, followed by cervical dislocation. Mice were bred in the animal facilities at the Albert Einstein College of Medicine and at the University Health Network (UHN) in Toronto, and sacrificed using CO~2~ followed by cervical dislocation under protocols respectfully approved by the Institutional Animal Care and Use Committee (IACUC) of the Albert Einstein College of Medicine (protocols 20080813, 20110803, 20140803 and 20170709) and the UHN Animal Care Committee.

After backcrossing 5--7 times to C57BL/6 J, the colony was maintained for several years by intercrossing heterozygotes and *Notch1*\[12f/12f\] homozygote progeny were viable and fertile. Following backcrossing to 11 or more generations, however, *Notch1*\[12f/12f\] homozygotes generally died during gestation. We analyzed a large number of embryos from this 1st cohort. We then reacquired viable *Notch1*\[12f/12f\] mice that we had previously sent to Toronto and which had been backcrossed to C57BL/6 for 3 generations and then intercrossed to derive \[12f/12f\] homozygotes. These mice were crossed once to C57BL/6 J mice at Albert Einstein and then heterozygotes were intercrossed to maintain a colony that generated viable *Notch1*\[12f/12f\] mice. Other *Notch1*\[12f/12f\] mice from Toronto were backcrossed to C57BL/6 J mice to 15 generations before heterozygotes were intercrossed. This colony was maintained as *Notch1*\[12f/+\] heterozygotes because *Notch1*\[12f/12f\] homozygotes were not viable. We analyzed numerous embryos from this 2nd cohort. 129S2/SvPasCrl mice were used to cross to the latter *Notch1*\[12f/+\] heterozygotes.

Genotyping of progeny was performed by PCR of genomic DNA from toe or yolk sac using forward primer Fwd-CGGAGTGACGGGTATGTAT and reverse primer Rev-GTGTGTGTTGTGGCAGGTTC which span a *lox p* site between exons 5 and 6 of the mouse *Notch1* locus \[[@CR15]\]. The *Notch1*\[+\] allele product was 458 bp and the *Notch1*\[12f\] allele product was 561 bp. Timed mating was performed to determine stage of embryonic death and to generate embryos for analysis. A time of 0.5 days of gestation was taken as the first morning that a vaginal plug was observed in a female who had been placed with a male the evening before. Embryos were staged according to established Theiler staging criteria \[[@CR26]\].

Southern blot analysis {#Sec10}
----------------------

Genomic DNA was prepared, digested with HindIII or KpnI, electrophoresed on an agarose gel, transferred to membrane and hybridized to a ^32^P-labeled probe as previously described \[[@CR15], [@CR44]\]. The probe was generated from genomic DNA with forward primer 5'AGTCACCTGTGGTTCCCTTG and reverse primer 5'AAGGGATGGGGAGAGAGAAA, gel purified and labeled with α-^32^P-dCTP using the Prime-It RmT Random Primer hybridization labeling kit (Agilent Technologies). After development, films were scanned and quantitated by NIH ImageJ.

In situ hybridization {#Sec11}
---------------------

In situ hybridization probes were prepared and used to perform in situ hybridization as described previously \[[@CR21], [@CR45]\]. Anti-PECAM1 antibody (BD Pharminogen, MEC13.3) binding to whole mount embryos was also performed as described previously \[[@CR18]\].

qPCR and qRT-PCR {#Sec12}
----------------

To determine copy number of *Notch1*\[+\] and *Notch1*\[12f\] alleles a qPCR strategy was employed. A standard number-of-molecules curve was performed with a plasmid containing a 100 bp fragment of the serum albumin precursor gene *Alb* and used in subsequent experiments to calculate the number of molecules in each sample. Numbers between 1,000 and 1,000,000 were within the linear range. Genomic DNA from wild type, *Notch1*\[12f/+\] and *Notch1*\[12f/12f\] progeny of *Notch1*\[12f/+\] heterozygote crosses was subjected to qPCR using the following primers: *Alb* Fwd-CAGGTGTCAACCCCAACTCT; Rev-CCACACAAGGCAGTCTCTGA; *Notch1*\[+\] Fwd-GGTTCTTGTGAGCTATTAGCAGCT; Rev-AAGATGAGCTCCCTGCTCTG; *Notch1*\[12F\] Fwd-TCCAGTTGGAGTCAGCACAG; Rev-CAGCCCAACCTGATCCTCTA. The amount of product from each allele compared to *Alb* was calculated and the ratio of alleles was determined and compared to a wild type C57BL/6 J genomic DNA standard.

To determine expression of Notch target genes, wild type and *Notch1*\[12f/12f\] embryos at E9.5 were genotyped from yolk sac genomic DNA and their heads were dissected for extraction of RNA using the Trizol method (Invitrogen). RNA amount was determined by nanodrop and 250 ng was reverse transcribed using a Verso cDNA kit (Thermo Fischer Scientific cDNA kit). Primers for *Notch1* RT-PCR (Additional file [4](#MOESM4){ref-type="media"}: Table S1) and for qRT-PCR of Notch target genes (Additional file [6](#MOESM6){ref-type="media"}: Table S2) were designed using NCBI Primer blast. PCR products of overlapping *Notch1* primers were generated and sent for sequencing by Macrogen. Primers used in qRT-PCR were shown to give single amplification products in an Applied Biosystems Viia 7 thermal cycler. Real time PCR was performed using 1 μl of the cDNA and Absolute Blue qPCR mix (Thermo Fischer Scientific). PCR conditions were 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s and 60 °C for 1 min. Gene expression relative to housekeeping genes (*Actb*, *Gapdh*) was calculated using the 2^-ddCt^ method as described \[[@CR46]\]. A Notch1 pathway RT^2^ Profiler PCR PAMM-259Z array (Qiagen) was also used to determine relative gene expression in control versus *Notch1*\[12f/12f\] cDNA preparations from embryonic brain. The array included 5 housekeeping genes.

Statistics {#Sec13}
----------

The significance of mouse progeny expected versus observed was determined by Chi-squared test. Numeric data were analyzed for significance using the unpaired Student's t test assuming both populations have the same STDEV for qRT-PCR or using Welch's correction for comparison of the number of somites in Prism, version 8.0, as noted.

Supplementary information
=========================

 {#Sec14}

**Additional file 1:** **Figure S1.** Morphology of E9.5 *Notch1*\[12f/12f\] embryos. Embryos were obtained at E9.5 and photographed under an inverted dissecting microscope. Their Theiler stage was determined by comparison of morphological features including number of somites, presence, delimitation and size of forelimb bud and hindlimb bud, branchial arch number and size, shape and size of the heart and head regions, olfactory placode indentation and closure of the otocyst. **Additional file 2:** **Figure S2.** Morphology of E10.5 *Notch1*\[12f/12f\] embryos. Embryos were obtained at E10.5 and photographed under an inverted dissecting microscope. Their Theiler stage was determined by comparison of morphological features including number of somites, presence, delimitation and size of forelimb bud and hindlimb bud, branchial arch number and size, shape and size of the heart and head regions, olfactory placode indentation and closure of the otocyst. **Additional file 3:** **Figure S3.** Vascularization of Notch1\[12f/12f\] embryos. Embryos were isolated at E10.5, their yolk sacs removed for genotyping, the tip of the PSM was removed for western analysis (see Additional file [4](#MOESM4){ref-type="media"}; Figure S4). Staining of fixed embryos with anti-PECAM1 antibody was performed as described previously \[[@CR1]\].1. Ge C, Stanley P: Effects of varying Notch1 signal strength on embryogenesis and vasculogenesis in compound mutant heterozygotes. *BMC Dev Biol* 2010, 10(1):36. **Additional file 4:** **Table S1.** Primers used to sequence *Notch*12f mRNA, NM_008714.3 **Additional file 5:** **Figure S4**. Notch1 activation in the presomitic mesoderm (PSM) of E10.5 embryos. The tip of the PSM was removed from a cohort of E10.5 embryos (see Additional file [3](#MOESM3){ref-type="media"}; Figure S3) and transferred to 40 μl Laemmli buffer, sonicated in a sonicating water bath for 5 min, heated at 90 °C for 15 min and frozen at − 20 °C. After thawing, 20 μl was analyzed by SDS-PAGE. After electrophoresis the gel was transferred to PVDF membrane, the membrane was cut at \~ 75 kDa and the upper portion was probed with anti-Val1744 Ab (Cell Signaling) for cleaved, activated NOTCH1 (NICD1) and binding was detected with HRP-conjugated anti-rabbit IgG. A positive control sample with NICD1 was included on the gel. GAPDH on the bottom portion was detected with primary mAb 5718 (R & D Systems) and HRP-conjugated anti-mouse IgG. The membrane was treated with Pierce West-Pico 34,095 ECL reagent for 5 min and exposed to film for various times. A 10 min exposure is shown. A replicate western blot with the same samples gave the same results. **Additional file 6:** **Table S2.** Primers used in qRT-PCR
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